The life science markets today are experiencing unprecedented change and facing key strategic challenges including: globalisation and the rise of emerging markets, ageing populations and demographic changes, patent expirations, funding, pressure on margin and speed to market – all of these combined have resulted in an extremely competitive life science landscape.
Redgrave Partners believes the key to success in this dynamic sector is through attracting and retaining strong executive talent, leaders who can pro-actively identify and address these issues; individuals who can drive change and deliver innovation through commerciality and creativity.
Redgrave creates a truly global network giving access to all areas of international talent reflecting the growth and success within both developed and emerging markets. The life science practice has an experienced and dedicated team of experts who have a track record in placing senior talent across all functional areas globally. By continually investing in building a comprehensive network of high-calibre individuals, underpinned by a dedicated in-house research function, we are able to provide our clients access to best in class.
Recent assignments include:
- SVP Head of Business Development and Licensing International – Global medical device manufacturer
- VP Regional Finance Director - Global medical device manufacturer
- VP Head of Business Development and Licensing – US global diversified pharmaceutical group
- Regional Finance Director - US global diversified pharmaceutical group
- Head of Market Access and External Affairs – Mid sized privately owned biopharmaceutical business
- Head of Global Emerging Markets - Mid sized privately owned biopharmaceutical business
- VP Global Market Access Strategy – European diversified pharmaceutical group
- Head of Scientific Affairs International - European diversified pharmaceutical group
- VP Head of Regulatory Affairs Emerging Markets – Global diversified healthcare group
- CEO – Biotech start-up